# US 2021/0330903 A1 · Multiple Dose Nasal Spray of Naloxone

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330903 A1
- Document ID: US20210330903A1
- Status: Published application
- Kind: A1
- Application number: 17/242,595
- Filed: 2021-04-28
- Published: 2021-10-28
- Earliest claimed: 2020-04-28
- Assignees: Navinta III Inc
- Applicants: Navinta III Inc
- Inventors: Sandipkumar Arvindbhai Patel
- Web page: https://patentgrep.com/patent/US20210330903A1

## CPC

- A61M 15/0066: {with means for varying the dose size}
- A61K 31/485: Morphinan derivatives, e.g. morphine, codeine
- A61M 15/0001: {Details of inhalators; Constructional features thereof}
- A61M 15/009: {using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08)}
- A61M 15/08: Inhaling devices inserted into the nose
- A61M 2202/04: Liquids
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A multiple dose Naloxone spray dosage form provides a container having two or more unit doses of Naloxone or a salt thereof in a liquid that is delivered by a metered dosage spray pump. In different embodiments, ten or more, 3-500, and 10-500 unit doses are provided in the container. The metered dosage spray pump delivers 50 to about 200 μL of Naloxone solution per spray, preferably, 100 μL per spray. Each unit dose contains about 0.5 mg to 12 mg of Naloxone or a pharmaceutically acceptable salt thereof, preferably, about 2 mg to 4 mg thereof in the delivered spray. A stable pharmaceutically acceptable composition of Naloxone is used in the multiple dose Naloxone spray dosage form. A method of treatment of opioid overdose involves administration of multiple doses using the multiple dose Naloxone spray dosage form.

## Claims

### Claim 1

A multiple dose Naloxone spray dosage form, comprising:
a container;
ten or more unit doses of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier contained in the container;
a metered dosage spray pump and actuator provided with the container;
wherein each unit dose metered by the metered dosage spray pump contains about 50 μL to about 200 μL of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier; and
wherein each unit dose metered by the metered dosage spray pump contains about 0.5 mg to 12 mg of Naloxone or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The multiple dose Naloxone spray dosage form of claim 1, wherein the container contains 10 to 500 unit doses of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier.

### Claim 3 (depends on 1)

The multiple dose Naloxone spray dosage form of claim 1, wherein the container contains about 1 to 50 mL of the Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier.

### Claim 4 (depends on 1)

The multiple dose Naloxone spray dosage form of claim 1, wherein a concentration of the Naloxone or pharmaceutically acceptable salt in the liquid nasal carrier is about 10 mg/m L to 60 mg/m L.

### Claim 5

A multiple dose Naloxone spray dosage form, comprising:
a container;
two or more unit doses of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier contained in the container;
a metered dosage spray pump and actuator provided with the container.

### Claim 6 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the container contains 10 or more unit doses of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier.

### Claim 7 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the container contains 3 to 500 unit doses of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier.

### Claim 8 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the metered dosage spray pump delivers about 50 to about 200 μL of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier upon actuation by a user.

### Claim 9 (depends on 8)

The multiple dose Naloxone spray dosage form of claim 8, wherein the metered dosage spray pump delivers about 100 μL of Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier upon actuation by a user.

### Claim 10 (depends on 7)

The multiple dose Naloxone spray dosage form of claim 7, wherein the container contains about 1 to 50 mL of the Naloxone or a pharmaceutically acceptable salt thereof in a liquid nasal carrier.

### Claim 11 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein a concentration of the Naloxone or pharmaceutically acceptable salt in the liquid nasal carrier is about 10 mg/m L to 60 mg/m L.

### Claim 12 (depends on 11)

The multiple dose Naloxone spray dosage form of claim 11, wherein each unit dose comprises 2 mg to 4 mg of Naloxone or a pharmaceutically acceptable salt thereof.

### Claim 13 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the intranasal carrier comprises a preservative.

### Claim 14 (depends on 13)

The multiple dose Naloxone spray dosage form of claim 13, wherein the preservative is phenyl ethyl alcohol.

### Claim 15 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the intranasal carrier comprises permeation enhancer selected from disodium edetate and caffeine.

### Claim 16 (depends on 5)

The multiple dose Naloxone spray dosage form of claim 5, wherein the intranasal carrier comprises acid sufficient to adjust pH to about 3 to about 6.

### Claim 17

A method of treating opioid overdose or toxicity in a patient by intranasally administering to the patient multiple doses of Naloxone in a liquid carrier contained in a multiple dose spray dispenser containing two or more unit doses of the Naloxone in a liquid carrier.

### Claim 18 (depends on 17)

The method of claim 17, wherein:
the multiple dose spray dispenser is placed in a first nostril of the patient, and the spray dispenser is actuated to spray the Naloxone in a liquid carrier in the first nostril;
the multiple dose spray dispenser is placed in a second nostril of the patient, and the spray dispenser is actuated to spray the Naloxone in a liquid carrier in the second nostril.

### Claim 19 (depends on 18)

The method of claim 18, further comprising:
repeating the steps of claim 18 procedure using same multiple dose spray dispenser every two to three minutes as needed.

### Claim 20 (depends on 17)

The method of claim 17, wherein each dose contains about 0.5 mg to 6 mg of Naloxone or a pharmaceutically acceptable salt thereof.
